What Makes SoCal a Leading Hub? - BIO Digital Chapter Panel Discussion
Join WIB for a
BIO Digital Chapter Panel Discussion
What Makes SoCal a Leading Hub?
Friday, June 12, 2020
12:00 - 1:15 pm PST
What is Southern California’s secret sauce? Why is it near the top of US biotech clusters, with key areas of VC dollars, patents, lab space, employment, and NIH funding, all trending up? Meet panelists in each of these key areas, and join us for an interactive discussion and thought leaders' perspectives on what’s coming next to Southern California.
This event is open to the general public and is part of the BIO Digital Online Discussion Series offered by WIB.
It is from 12:00 p.m. - 1:15 p.m. PDT/3:00 p.m. - 4:15 p.m. EDT
David H. Crean, Ph.D. is a Managing Director at Objective Capital Partners, a middle-market investment banking firm located in southern California, where he leads the firm’s Mergers and Acquisitions (M&A), partnering, valuations and capital financing transactions with life science and healthcare companies.
Dr. Lisa Haile is a partner at the global law firm DLA Piper and based in their San Diego, California office. Her practice focuses on strategic counseling relating to all areas of biotechnology, pharmaceutical, and life sciences intellectual property law.
Julio de Unamuno IV is the Founder & CEO of LabFellows, the largest independent provider of lab operations management solutions with over $300M lab spend and over 1 million square feet of lab space under management across the U.S.
Elizabeth Hewitt Gibson joined the California Life Sciences Association (CLSA) in September 2016. As the Vice President of Marketing, Programs, and Talent, she directs all aspects of CLSA’s talent and organizational development, program creation, and logistics for CLSA’s 90-100 statewide conferences and events, inbound, digital and print marketing, and membership experience.
Please forward invite to colleagues and friends from other organizations who may be interested .